ArticleExperimental hematology2015

CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells.

Rowan Flynn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.